Biotech stocks, especially those that don’t have a medicine on the market yet, tend to be among the riskiest investments available. Even under the best of conditions, clinical tria… Read More
Clinscience and Ryvu Therapeutics sign Knowledge Administration and Biostatistics Settlement for RVU120 Section II Medical Trials in Hematology
Clinscience is thrilled to companion wit… Read More
Antibody Drug Conjugate (ADC) is a complex formed by linking cytotoxic drugs to tumor-targeting monoclonal antibodies. It combines the characteristics of targeted drugs and chemoth… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myelodysplastic Syndrome pipeline constitutes 120+ key companies continuously working towards developin… Read More
On May 11, 2023, Century Therapeutics (NASDAQ: IPSC) released its Q1 earnings report at 07:30 AM. Despite missing estimated earnings by 1.92%, the company reported a revenue increase of $662… Read More
If there’s one particular way to explain the markets a short while ago, that would be top-hefty. The mega-caps, the biggest US companies, have been outperforming the broader… Read More
“Orphan” drug status is offering these ASX pharma stocks a chance to turn a healthy profit – and give hope to those suffering rare conditions.
Rare or “orphan&rd… Read More
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported achievement of another technical milestone in its drug di… Read More
The ‘Global Acute Myeloid Leukemia Treatment Market Share, Size, Report and Forecast 2023-2031’ by Expert Market Research gives an extensive outlook of the global acute myeloid l… Read More
CK1 functions
Protein phosphorylation mediated by protein kinases is essential for the activation and deactivation of many signaling pathways in cells. As a result, abnormal protein kinas… Read More
DelveInsight’s, “Acute Myeloid Leukemia Pipeline Insight 2023,” report provides comprehensive insights about 260+ companies and 260+ pipeline drugs in the Acute Myeloid Le… Read More
Delveinsight Business Research LLP
As per DelveInsight, the Relapsed or Refractory Myelodysplastic Syndrome Therapeutics Market dynamics are expected to transform in the coming years ow… Read More
It was supposed to be a very quiet stock market session ahead of a pivotal inflation report and the last FOMC meeting of the year. There was a lot of positive news to start the week… Read More
Immunotherapy is one of the most exciting and promising new developments in cancer treatment. By taking advantage of the patient’s immune system to attack tumors, immunotherapy provi… Read More
Actinium Pharmaceuticals (NYSE AMERICAN: ATNM) is forging its own pathway in treating underserved diseases. And, for cancer patients, especially those resistant to or untreatable by current… Read More
The American Cancer Society in 2020 estimated around 60,530 cases of Acute Myeloid Leukemia (AML) in the US, with 11,180 cases of death post-suffering the illness. The impact of Leukemia isn… Read More
The market for leukemia therapeutics is mainly driven by the high
prevalence of the disease. Asia and Europe have high prevalence rates of
leukemia, followed by North America, making these… Read More
The post SMALL CAP SHARE IDEAS: Bivictrix Therapeutics appeared first on TodayHeadline.
Often the treatment of cancer is a high wire act for a physician, who has to administer the optimal… Read More
InspiredImages / Pixabay
The News:
We’re hardly in a recession, and most forms of healthcare spending remain incredibly robust, regardless of what the overall economy does and what the… Read More
New Year arrives as US exceeds 20 million COVID-19 cases.
America just surpassed 20 million COVID-19 cases, nearly a year after a mysterious germ first revealed itself in Wuhan, China. That… Read More
geralt / Pixabay
President Trump released from hospital after COVID-19 diagnosis; doctors add steroid used in treating more severe patients.
President Trump, eager to demonstrate that his co… Read More
As the global leaders in Pharmaceutical Industry, the United States of America is home to some of the most reputed pharmaceutical companies alongside Europe. As clinical science and innovati… Read More